Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds
- PMID: 33135527
- PMCID: PMC7780580
- DOI: 10.1177/0300060520969087
Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds
Abstract
Objective: This study compared the diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxyprothrombin (DCP) in early-stage hepatitis B virus-related hepatocellular carcinoma (HBV-HCC) under different backgrounds.
Methods: Patients were enrolled and divided in four groups: chronic HBV infection (CHB), liver cirrhosis (LC), early-stage CHB-HCC, and early-stage LC-HCC. Serum AFP and DCP levels were measured. Receiver-operating characteristic (ROC) curve and area under the curve (AUC) analyses were applied to compare the diagnostic performance of DCP and AFP for HCC.
Results: In total, 200 patients were enrolled, including 48, 64, 33, and 55 patients with CHB, LC, CHB-HCC, and LC-HCC, respectively. ROC curve analysis revealed that the AUCs of AFP, DCP, and their combination in differentiating early-stage LC-HCC from LC were 0.776, 0.758, and 0.786, respectively. The values of these markers in discriminating early-stage CHB-HCC from CHB were 0.828, 0.731, and 0.862, respectively.
Conclusions: DCP was inferior to AFP in differentiating early-stage CHB-HCC from CHB. However, AFP and DCP displayed similar performance in distinguishing early-stage LC-HCC and LC.
Keywords: Des-gamma-carboxyprothrombin; alpha-fetoprotein; chronic hepatitis B; diagnostic performance; hepatitis B virus; hepatocellular carcinoma; liver cirrhosis.
Conflict of interest statement
Figures


Similar articles
-
Diagnostic value of alpha-fetoprotein, Lens culinaris agglutinin-reactive alpha-fetoprotein, and des-gamma-carboxyprothrombin in hepatitis B virus-related hepatocellular carcinoma.J Int Med Res. 2020 Mar;48(3):300060519889270. doi: 10.1177/0300060519889270. Epub 2019 Dec 18. J Int Med Res. 2020. PMID: 31852373 Free PMC article.
-
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19. J Gastroenterol Hepatol. 2008. PMID: 18422961
-
Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.PLoS One. 2016 Apr 12;11(4):e0153227. doi: 10.1371/journal.pone.0153227. eCollection 2016. PLoS One. 2016. PMID: 27070780 Free PMC article.
-
Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.Clin Liver Dis. 2015 May;19(2):309-23. doi: 10.1016/j.cld.2015.01.005. Epub 2015 Feb 27. Clin Liver Dis. 2015. PMID: 25921665 Review.
-
Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis.Biomed Res Int. 2020 Sep 17;2020:5087643. doi: 10.1155/2020/5087643. eCollection 2020. Biomed Res Int. 2020. PMID: 33015170 Free PMC article.
Cited by
-
Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular Carcinoma.In Vivo. 2021 May-Jun;35(3):1749-1760. doi: 10.21873/invivo.12434. In Vivo. 2021. PMID: 33910859 Free PMC article.
-
Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.Diagnostics (Basel). 2023 Feb 21;13(5):816. doi: 10.3390/diagnostics13050816. Diagnostics (Basel). 2023. PMID: 36899960 Free PMC article.
-
Diagnostic Value of hTERT mRNA and in Combination With AFP, AFP-L3%, Des-γ-carboxyprothrombin for Screening of Hepatocellular Carcinoma in Liver Cirrhosis Patients HBV or HCV-Related.Cancer Inform. 2022 May 20;21:11769351221100730. doi: 10.1177/11769351221100730. eCollection 2022. Cancer Inform. 2022. PMID: 35614962 Free PMC article.
-
Hepatocellular Carcinoma: The Search for an Optimal Screening Test.Middle East J Dig Dis. 2025 Jan;17(1):31-39. doi: 10.34172/mejdd.2025.407. Epub 2025 Jan 31. Middle East J Dig Dis. 2025. PMID: 40322566 Free PMC article. Review.
-
The prognostic potential of fragmented CK18 serum levels in HCC patients reflecting disease progression and overall hepatocyte damage.Front Oncol. 2022 Aug 23;12:993705. doi: 10.3389/fonc.2022.993705. eCollection 2022. Front Oncol. 2022. PMID: 36081568 Free PMC article.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2017; 67: 7. - PubMed
-
- Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 2007; 82: 967–975. - PubMed
-
- Nagaratnam N, Nagaratnam K, Cheuk G. Hepatocellular Carcinoma. In: Geriatric Diseases. Berlin: Springer. 2017.
-
- European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol 2012; 57: 167–185. DOI: 10.1016/j.jhep.2012.02.010 S0168-8278(12)00167-5 [pii]. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous